The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
nab-Sirolimus for patients with advanced malignant PEComa with or without prior mTOR inhibitors: Biomarker results from AMPECT and an expanded access program.
 
Mark Andrew Dickson
Consulting or Advisory Role - Celgene
Research Funding - AADi (Inst); Lilly (Inst)
 
Vinod Ravi
Stock and Other Ownership Interests - AstraZeneca; Merck; Moderna Therapeutics; Pfizer; TRACON Pharma
Consulting or Advisory Role - Daiichi Sankyo
Research Funding - AADi (Inst); Athenex (Inst); Novartis (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties from Uptodate
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Richard F. Riedel
Employment - Limbguard (I)
Leadership - Limbguard (I)
Stock and Other Ownership Interests - Limbguard (I)
Consulting or Advisory Role - Bayer; Blueprint Medicines; Daiichi Sankyo; Deciphera; Ignyta; Loxo; NanoCarrier; SpringWorks Therapeutics
Research Funding - AADi (Inst); Arog (Inst); Bayer (Inst); Blueprint Medicines (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Immune Design (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); NanoCarrier (Inst); Philogen (Inst); Plexxikon (Inst); Roche/Genentech (Inst); SpringWorks Therapeutics (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - PandoNet - Limbguard (I)
Travel, Accommodations, Expenses - Daiichi Sankyo; Ignyta; NanoCarrier
 
Kristen N. Ganjoo
Consulting or Advisory Role - Deciphera; Foundation Medicine
 
Brian Andrew Van Tine
Leadership - Polaris
Honoraria - Bionest Partner; Horizon CME; Research to Practice; Targeted Oncology
Consulting or Advisory Role - Adaptimmune; ADRx; Apexigen; Ayala Pharmaceuticals; Bayer; Cytokinetics; Daiihi Sankyo; Deciphera; EMD Serono; Epizyme; GlaxoSmithKline; Immune Design; Intellisphere; Lilly; Novartis; Pfizer
Speakers' Bureau - Adaptimmune; GlaxoSmithKline; Lilly; Novartis
Research Funding - GlaxoSmithKline; Merck; Pfizer; TRACON Pharma
Patents, Royalties, Other Intellectual Property - Accuronix Therapeutics- Licensing agreement. Sigma-2 Receptor Ligands and Therapeutic uses therefor (006766), • Modular Platform for Targeted Therapeutic Delivery (006755), • Sigma-2 Receptor Ligand Drug Conjugates as Antitumor Compounds, Methods of synth; Patent on ALEXT3102; Patent on the use of ME1 as a biomarker
Expert Testimony - Health Advances
Travel, Accommodations, Expenses - Adaptimmune; Advenchen Laboratories; GlaxoSmithKline; Lilly
 
Rashmi Chugh
Consulting or Advisory Role - Deciphera; Epizyme; Ipsen
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals; Epizyme (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Medivation (Inst); Mundipharma (Inst); Novartis (Inst); Plexxikon (Inst); Qilu Puget Sound Biotherapeutics (Inst); SpringWorks Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Wolters Kluwer
Expert Testimony - DOPF, PC; Meyers Law (Inst)
 
Lee D. Cranmer
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); Astellas Pharma (Inst); CBA Research (Inst); Exelixis (Inst); Iterion Therapeutics (Inst); Lilly (Inst); Merck (Inst); Philogen (Inst); TRACON Pharma (Inst)
 
Erlinda Maria Gordon
Stock and Other Ownership Interests - Counterpoint Biomedica; Delta Next-Gene
Speakers' Bureau - AADi
Research Funding - Bristol Mers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of patents on targeting pharmaceutical agents to injured tissues
 
James Lin Chen
Consulting or Advisory Role - Syapse; Tempus
Speakers' Bureau - Foundation Medicine
Research Funding - Eisai
Patents, Royalties, Other Intellectual Property - MatchTX
 
Martina Cathryn Murphy
Honoraria - North American Thrombosis Forum
Consulting or Advisory Role - Pfizer
 
Anita N. Schmid
Employment - AADi
Stock and Other Ownership Interests - AADi
 
Neil Desai
Employment - AADi
Leadership - AADi
Stock and Other Ownership Interests - AADi
Research Funding - AADi
Patents, Royalties, Other Intellectual Property - I hold patents as an employee of Aadi Bioscience Inc
Travel, Accommodations, Expenses - AADi
 
Norma Alonzo Palma
Employment - AADi; Agios; Foundation Medicine; Foundation Medicine
Stock and Other Ownership Interests - Agios; Foundation Medicine
Other Relationship - AADi
 
David J. Kwiatkowski
Consulting or Advisory Role - AADI; Genentech/Roche
Research Funding - AADi; Genentech/Roche; Revolution Medicines
 
Andrew J. Wagner
Honoraria - Deciphera
Consulting or Advisory Role - AADi; Boehringer Ingelheim; Cogent Biosciences; Daiichi Sankyo; Deciphera; Epizyme; Lilly; Mundipharma
Research Funding - AADi (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); Foghorn Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Plexxikon (Inst); Rain Therapeutics (Inst)